The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
GeDDiS: A prospective randomised controlled phase III trial of gemcitabine and docetaxel compared with doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft tissue sarcomas (EudraCT 2009-014907-29).
 
Beatrice M. Seddon
Honoraria - Pfizer
Consulting or Advisory Role - ARIAD
Travel, Accommodations, Expenses - GlaxoSmithKline; PharmaMar
 
Jeremy Whelan
No Relationships to Disclose
 
Sandra J Strauss
Consulting or Advisory Role - Champions Oncology
Travel, Accommodations, Expenses - PharmaMar
 
Michael Gordon Leahy
Stock and Other Ownership Interests - GlaxoSmithKline
Honoraria - GlaxoSmithKline; Pfizer
Research Funding - AB Science; GlaxoSmithKline; Novartis; Pfizer; PharmaMar
Travel, Accommodations, Expenses - PharmaMar
 
Penella J. Woll
Honoraria - Amgen; GlaxoSmithKline
Speakers' Bureau - Amgen; GlaxoSmithKline
Research Funding - AstraZeneca; Pfizer; Virttu Biologics
Travel, Accommodations, Expenses - Bristol-Myers Squibb; PharmaMar
 
Fiona Cowie
No Relationships to Disclose
 
Christian Alexander Rothermundt
Consulting or Advisory Role - Astellas Pharma; Pfizer; Takeda
Research Funding - Astellas Pharma (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Zoe Wood
No Relationships to Disclose
 
Sharon Forsyth
No Relationships to Disclose
 
Iftekhar Khan
No Relationships to Disclose
 
Stephen Nash
No Relationships to Disclose
 
Paul Patterson
No Relationships to Disclose
 
Sandra Beare
No Relationships to Disclose